Gilead Announces Funding Initiative to Support HIV Prevention, Anti-Stigma and Health Equity Efforts for Black Cisgender and Transgender Women and Girls in the U.S.
February 27 2024 - 10:00AM
Business Wire
– 19 Organizations Will Receive a Total of
$12.6 Million in Grant Funding Through Gilead’s Setting the
P.A.C.E. Initiative –
Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is
providing a total of $12.6 million in grant funding to 19
organizations working to improve the HIV landscape for Black women
and girls in the United States. These grants are a part of Gilead’s
new Setting the P.A.C.E. (Prevention, Arts and Advocacy, Community,
Education) initiative, a three-year commitment toward increasing
HIV prevention, anti-stigma and health equity efforts for Black
cisgender and Transgender women and girls, who are
disproportionately impacted by the HIV epidemic.
In 2021, Black women accounted for 53% of new HIV diagnoses
among women aged 16 and older in the United States, despite
comprising only 14% of the women living in the country.
Additionally, Black Transgender women have the highest rates of new
HIV diagnoses among Transgender people and are more likely to go
undiagnosed and untreated in comparison to their peers. These
inequities are exacerbated by significant gaps in the delivery of
effective and culturally relevant HIV prevention information and
care services for Black women and girls.
“By taking a strategic, community-centered approach to address
systemic disparities and improve overall health outcomes, Gilead
continues its commitment to advancing health equity for Black
cisgender and Transgender women and girls in the U.S. who continue
to be disproportionately impacted by the HIV epidemic,” said
Deborah H. Telman, Executive Vice President, Corporate Affairs and
General Counsel, Gilead Sciences. “Gilead’s Setting the P.A.C.E.
initiative will help empower organizations to expand custom
programs tailored toward fighting stigma and expanding access to
HIV care in their communities.”
Through this investment, Setting the P.A.C.E. grantee
organizations will develop and support a variety of impactful
projects to help improve health outcomes for Black women and girls,
from expanding programs that provide culturally-responsive HIV care
training, to leveraging arts and media to engage local communities
and address stigma. Importantly, more than 75% of the organizations
selected for grants are led by Black women and every funding
allocation is directed toward initiatives led or co-led by Black
women. Additionally, the states in which programming will be
implemented align with states that have higher numbers of Black
women living with HIV.
“Gilead’s Setting the P.A.C.E. grant marks a pivotal moment for
Ribbon and the communities we serve across the nation,” said Linda
H. Scruggs, Co-Executive Director, Ribbon. “Gilead’s support
enables us to form collaborative partnerships and programs to help
end the disparities in HIV awareness, prevention and care. Our
focus on the intersection of Black cisgender and Transgender women
in relation to HIV is not just about addressing an unmet need, it's
about rewriting narratives and changing destinies. Ribbon is
dedicated to creating a future where access to HIV education and
resources is a right, not a privilege, and where every person,
regardless of their identity, can live a life of health, dignity
and opportunity.”
The 19 Gilead Setting the P.A.C.E. grantees are:
- A New Way of Life Reentry Project (Los Angeles,
California)
- AIDS United (Washington, D.C.)
- Baltimore Safe Haven (Baltimore, Maryland)
- California Black Women’s Health Project (Inglewood,
California)
- Dancing Grounds (New Orleans, Louisiana)
- Foundations for Living Incorporated (Jefferson, Georgia)
- Howard University (Washington, D.C.)
- National Association of Black Social Workers (Washington,
D.C.)
- Power Safe Place Resource Center of Virginia (Front Royal,
Virginia)
- Ribbon, Inc. (Largo, Maryland)
- San Francisco Community Health Center (San Francisco,
California)
- SisterLove, Inc. (Atlanta, Georgia)
- SLK Health Services Corporation (Lanham, Maryland)
- The Black Women’s Learning Institute (BWLI) at NDRI-USA, Inc.
(New York, New York)
- Transinclusive Group (Pembroke Pines, Florida)
- Triumphant Together (Kissimmee, Florida)
- Unspoken Treasure Society (Gainesville, Florida)
- Waco Theater Center (Hollywood, California)
- WeCareTn (Memphis, Tennessee)
Gilead’s Setting the P.A.C.E. initiative aims to empower local
organizations to address ongoing health inequities in care and
treatment through four key programmatic areas: HIV prevention, arts
and advocacy, community and education. The program builds on
Gilead’s longstanding commitment toward investing in Black women’s
health and leadership through philanthropy. In addition to this new
funding, the company has provided more than $35.8 million in
philanthropic support for Black women-led and/or Black
women-serving organizations in the United States since 2017. More
than $28 million of those investments were granted to organizations
working to help end the HIV epidemic.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has
pursued and achieved breakthroughs in medicine for more than three
decades, with the goal of creating a healthier world for all
people. The company is committed to advancing innovative medicines
to prevent and treat life-threatening diseases, including HIV,
viral hepatitis, COVID-19, and cancer. Gilead operates in more than
35 countries worldwide, with headquarters in Foster City,
Calif.
Gilead and the Gilead logo are trademarks of
Gilead Sciences, Inc., or its related companies.
For more information about Gilead, please visit
the company’s website at www.gilead.com, follow Gilead on X/Twitter
(@Gilead Sciences) and LinkedIn (@Gilead-Sciences).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240227849231/en/
Jacquie Ross, Investors Investor_relations@gilead.com
Meaghan Smith, Media Public_affairs@gilead.com
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024